Evidence map›Paper›PMID 40085329›Full record

ArticleMycotoxin research2025

Protective effect of curcumin against endoplasmic reticulum stress and lipid metabolism disorders in AFB1-intoxicated duck liver.

Qian Su, Hang Pan, Panjing Hong, Yanli You, Yuhan Wu, Junbo Zou, Jingping Sun, Gan Rao, Jianzhao Liao, Zhaoxin Tang and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mycotoxin research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Research status of several programmed cell death in the toxic effect of AFBApoptosis : an international journal on programmed cell death · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qian SuCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Hang PanCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Panjing HongCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Yanli YouCollege of Life Science, Yantai University, Yantai City, 264005, Shandong Province, China.
Yuhan WuCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Junbo ZouCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Jingping SunCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Gan RaoGuangzhou General Pharmaceutical Research Institute Co., Ltd, Guangzhou, China.
Jianzhao LiaoCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Zhaoxin TangCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
Lianmei HuCollege of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China. hulianmei@scau.edu.cn.

Funding

Guangxi Key Laboratory of Veterinary Biotechnology Cooperation Fund project 19-50-40-B-04Guangzhou Science and Technology Project 202102080601Independent research project of Guangxi Key Laboratory of Veterinary Biotechnology 20-065-23-A-2National Key R&D Program of China 2023YFD1801100Open Fund of Guangxi Key Laboratory of Veterinary Biotechnology 22-035-32-B-02
6 · The paper itself

Abstract

Aflatoxin B1 (AFB1) is a stable and highly toxic toxin that causes multi-organ toxicity with sustained ingestion, most typically in the duck liver. Previous research has shown that AFB1 can bring about endoplasmic reticulum stress (ERS) in animals, and ERS is strongly associated with lipid metabolism. However, the relationship between AFB1-induced duck liver toxicity and ERS and lipid metabolism is currently unclear. Great attention has been paid to the prevention and treatment of AFB1 because of its great harm. Curcumin, a natural polyphenol, is notable for its powerful anti-inflammatory and antioxidant properties. Studies have shown curcumin to be protective against afb1-induced avian multi-organ toxicity. However, the effects of curcumin on the liver of ducks exposed to AFB1 are largely unknown. In the present study, we aimed to investigate whether AFB1 exposure induces ERS and lipid metabolism disorders in duck liver, while exploring the positive role of curcumin in it. One-day-old ducks (n = 80) were randomly divided in four groups: control group, AFB1 group (0.1 mg / kg.bw AFB1), Cur group (400 mg/kg curcumin), and AFB1 + Cur group (0.1 mg/kg.bw AFB1 + 400 mg/kg curcumin), and blood and liver were collected for the study after 21 days of continuous administration. Our research has found that AFB1 exposure significantly increases the levels of liver function indicators ALP, AST, and ALT in ducks' serum (P < 0.05). Duck liver undergoes fatty degeneration under the influence of AFB1. Under the effect of curcumin, AFB1-induced structural damage in duck liver was somewhat controlled. Further experimental results showed that AFB1 treatment significantly increased the expression of glucose-regulated protein 78 (P < 0.001), and activated the endoplasmic reticulum stress pathway. Meanwhile, AFB1 inhibited the LKB1-AMPK signaling pathway and disrupted lipid metabolic homeostasis. And curcumin treatment effectively reversed these changes. Overall, our results suggest that curcumin attenuates AFB1-induced hepatotoxicity in ducks by inhibiting ERS and lipid metabolism disorders.

Indexed as

Aflatoxin B1CurcuminEndoplasmic Reticulum StressLipid MetabolismLipid Metabolism DisordersLiverProtective AgentsAnimalsDucksAflatoxin B1CurcuminProtective AgentsAFB1CurcuminDuckEndoplasmic reticulum stressLipid metabolismLiver

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.